• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KLASS-02-QC评估评分对KLASS-02手术结果的预测价值:D2淋巴结清扫术中外科医生质量控制与标准化的验证

Predictive Value of KLASS-02-QC Assessment Score on KLASS-02 Surgical Outcomes: Validation of Surgeon Quality Control and Standardization for D2 Lymphadenectomy.

作者信息

Song Jeong Ho, Shin Hye Jung, Hyung Woo Jin, Yang Han-Kwang, Han Sang-Uk, Park Young-Kyu, Lee Hyuk-Joon, An Ji Yeong, Kim Wook, Kim Hyung-Ho, Ryu Seung Wan, Hur Hoon, Kim Min-Chan, Kong Seong-Ho, Kim Jin-Jo, Park Do Joong, Kim Young Woo, Ryu Keun Won, Kim Jong Won, Lee Joo-Ho, Kim Hyoung-Il

机构信息

Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea.

Department of Surgery, Ajou University School of Medicine, Suwon, South Korea.

出版信息

Ann Surg. 2023 Nov 1;278(5):e1011-e1017. doi: 10.1097/SLA.0000000000005810. Epub 2023 Jan 23.

DOI:10.1097/SLA.0000000000005810
PMID:36727760
Abstract

OBJECTIVE

The aim of this study was to audit the 22 items and assessed each item's predictive value on surgical outcomes.

BACKGROUND

The KLASS-02 trial revealed that the oncologic outcomes of laparoscopic distal gastrectomy are not inferior to open distal gastrectomy in patients with advanced gastric cancer. The surgeons participating in this trial were chosen based on the assessment scores from the KLASS-02-QC trial, which used 22 items for standardization of D2 lymphadenectomy and quality control.

METHODS

We reviewed proficiency scores (PSs) for 22 items for 20 surgeons who participated in KLASS-02. The surgeons were divided into 2 groups according to PS, and the perioperative outcomes of 924 patients enrolled in KLASS-02 were compared between groups. Each item's predictive value for perioperative outcome was then assessed using multivariable regression models.

RESULTS

Of the total 924 patients, 529 were operated on by high-score surgeons (high PS) and 395 were operated on by low-score surgeons (low-PS). High-PS group had less intraoperative blood loss, longer operation times, and fewer complications, major complications, reoperations, and shorter first flatus and hospital stay than low-PS group ( P =0.006, P <0.001, P <0.001, P <0.001, P =0.042, P =0.013, and P <0.001, respectively). Some items used in KLASS-02-QC predicted perioperative outcomes, such as intraoperative blood loss, major complications, reoperation, and hospital stay.

CONCLUSIONS

Although this study only analyzed data associated with qualified surgeons, the 22 items effectively assessed the surgeons based on PS. A high score was associated with longer operation times, but better perioperative outcomes.

摘要

目的

本研究旨在审核这22项指标,并评估每项指标对手术结果的预测价值。

背景

KLASS - 02试验表明,在进展期胃癌患者中,腹腔镜远端胃切除术的肿瘤学结果并不劣于开放远端胃切除术。参与该试验的外科医生是根据KLASS - 02 - QC试验的评估分数挑选出来的,该试验使用22项指标来规范D2淋巴结清扫和质量控制。

方法

我们回顾了参与KLASS - 02的20名外科医生的22项指标的熟练度评分(PS)。根据PS将外科医生分为两组,并比较了KLASS - 02中924例患者的围手术期结果。然后使用多变量回归模型评估每项指标对围手术期结果的预测价值。

结果

在总共924例患者中,529例由高分外科医生(高PS)进行手术,395例由低分外科医生(低PS)进行手术。高PS组与低PS组相比,术中出血量更少、手术时间更长、并发症、主要并发症、再次手术更少,首次排气时间和住院时间更短(分别为P = 0.006、P < 0.001、P < 0.001、P < 0.001、P = 0.042、P = 0.013和P < 0.001)。KLASS - 02 - QC中使用的一些指标可预测围手术期结果,如术中出血量、主要并发症、再次手术和住院时间。

结论

尽管本研究仅分析了与合格外科医生相关的数据,但这22项指标基于PS有效地评估了外科医生。高分与更长的手术时间相关,但围手术期结果更好。

相似文献

1
Predictive Value of KLASS-02-QC Assessment Score on KLASS-02 Surgical Outcomes: Validation of Surgeon Quality Control and Standardization for D2 Lymphadenectomy.KLASS-02-QC评估评分对KLASS-02手术结果的预测价值:D2淋巴结清扫术中外科医生质量控制与标准化的验证
Ann Surg. 2023 Nov 1;278(5):e1011-e1017. doi: 10.1097/SLA.0000000000005810. Epub 2023 Jan 23.
2
Standardization of D2 lymphadenectomy and surgical quality control (KLASS-02-QC): a prospective, observational, multicenter study [NCT01283893].D2 淋巴结清扫术的标准化和手术质量控制(KLASS-02-QC):一项前瞻性、观察性、多中心研究 [NCT01283893]。
BMC Cancer. 2014 Mar 19;14:209. doi: 10.1186/1471-2407-14-209.
3
Surgeon Quality Control and Standardization of D2 Lymphadenectomy for Gastric Cancer: A Prospective Multicenter Observational Study (KLASS-02-QC).胃癌 D2 淋巴结清扫术的外科医师质量控制和标准化:一项前瞻性多中心观察研究(KLASS-02-QC)。
Ann Surg. 2021 Feb 1;273(2):315-324. doi: 10.1097/SLA.0000000000003883.
4
Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT).腹腔镜与开腹胃癌根治术治疗局部进展期胃癌的多中心随机对照研究(KLASS-02-RCT)的短期疗效观察。
Ann Surg. 2019 Dec;270(6):983-991. doi: 10.1097/SLA.0000000000003217.
5
Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.腹腔镜辅助进展期胃癌根治术的长期疗效:KLASS-02 RCT 随机临床试验。
J Clin Oncol. 2020 Oct 1;38(28):3304-3313. doi: 10.1200/JCO.20.01210. Epub 2020 Aug 20.
6
Feasibility and safety comparison of laparoscopy-assisted versus open gastrectomy for advanced gastric carcinoma with D2 lymphadenectomy.腹腔镜辅助与开腹胃癌D2淋巴结清扫术治疗进展期胃癌的可行性及安全性比较
Jpn J Clin Oncol. 2016 Apr;46(4):323-8. doi: 10.1093/jjco/hyw001. Epub 2016 Feb 4.
7
Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.比较腹腔镜远端胃癌切除术(D2淋巴结清扫术加完整胃系膜切除术,D2+CME)与传统D2淋巴结清扫术治疗局部进展期胃腺癌的前瞻性随机对照试验:一项随机对照试验的研究方案
Trials. 2018 Aug 9;19(1):432. doi: 10.1186/s13063-018-2790-5.
8
[Feasibility, safety and long-term efficacy of laparoscopic total gastrectomy combined with distal pancreaticosplenectomy for T4b gastric cancer].腹腔镜全胃切除术联合远端胰腺脾切除术治疗T4b期胃癌的可行性、安全性及长期疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 25;23(2):163-169. doi: 10.3760/cma.j.issn.1671-0274.2020.02.012.
9
Robotic-assisted versus conventional laparoscopic-assisted total gastrectomy with D2 lymphadenectomy for advanced gastric cancer: short-term outcomes at a mono-institution.机器人辅助与传统腹腔镜辅助D2淋巴结清扫全胃切除术治疗进展期胃癌:单中心短期疗效
BMC Surg. 2019 Jul 9;19(1):86. doi: 10.1186/s12893-019-0549-x.
10
Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial.腹腔镜D2淋巴结清扫术式全胃切除术治疗局部进展期胃癌的疗效:KLASS-02多中心随机对照临床试验方案
BMC Cancer. 2015 May 5;15:355. doi: 10.1186/s12885-015-1365-z.

引用本文的文献

1
Safety and Efficacy of Reduced-Port Versus Conventional Laparoscopic Distal Gastrectomy for Early Gastric Cancer: A Multicenter, Randomized, Non-inferiority Trial (KLASS-12).早期胃癌缩小切口与传统腹腔镜远端胃切除术的安全性和有效性:一项多中心、随机、非劣效性试验(KLASS-12)
J Gastric Cancer. 2025 Jul;25(3):437-454. doi: 10.5230/jgc.2025.25.e34.
2
Dynamic key vascular anatomy dataset for D2 lymph node dissection during laparoscopic gastric cancer surgery.腹腔镜胃癌手术中D2淋巴结清扫的动态关键血管解剖数据集
Sci Data. 2025 May 29;12(1):903. doi: 10.1038/s41597-025-05255-7.
3
Effect of visceral obesity on outcomes of fluorescence-guided lymphadenectomy during laparoscopic gastrectomy for gastric cancer: analysis of a randomized phase 3 trial.
内脏肥胖对胃癌腹腔镜胃切除术中荧光引导淋巴结清扫术结局的影响:一项随机3期试验的分析
Chin J Cancer Res. 2024 Oct 30;36(5):503-516. doi: 10.21147/j.issn.1000-9604.2024.05.04.
4
Enhancing Preoperative Diagnosis Accuracy of Stage III Gastric Cancer with Circulating circRNAs.利用循环环状RNA提高III期胃癌的术前诊断准确性
Ann Surg Oncol. 2025 Jan;32(1):333-341. doi: 10.1245/s10434-024-16387-2. Epub 2024 Oct 21.
5
Artificial intelligence for surgical safety during laparoscopic gastrectomy for gastric cancer: Indication of anatomical landmarks related to postoperative pancreatic fistula using deep learning.人工智能在腹腔镜胃癌根治术中的手术安全性:利用深度学习预测与术后胰瘘相关的解剖学标志。
Surg Endosc. 2024 Oct;38(10):5601-5612. doi: 10.1007/s00464-024-11117-x. Epub 2024 Aug 2.
6
Evolution in Laparoscopic Gastrectomy From a Randomized Controlled Trial Through National Clinical Practice.腹腔镜胃切除术的演变:一项随机对照试验到国家临床实践。
Ann Surg. 2024 Mar 1;279(3):394-401. doi: 10.1097/SLA.0000000000006162. Epub 2023 Nov 23.